Balance Sheet Data
Knight Therapeutics Inc. (GUD.TO)
$4.48
-0.36 (-7.44%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 787.88 | 703.82 | 430.62 | 411.34 | 162.99 | 20,698.24 | 55,206.44 | 147,246.92 | 392,737.76 | 1,047,512.23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 2 | 3 | 103 | 63 | 55 | 413.48 | 1,102.83 | 2,941.46 | 7,845.49 | 20,925.53 |
| Account Receivables (%) | ||||||||||
| Inventories | 1.22 | 1.14 | 70.87 | 56.50 | 72.40 | 299.56 | 798.99 | 2,131.07 | 5,684 | 15,160.40 |
| Inventories (%) | ||||||||||
| Accounts Payable | 0.54 | 0.75 | 72.83 | 44.51 | 65.31 | 279.07 | 744.35 | 1,985.33 | 5,295.29 | 14,123.63 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.13 | -3.87 | -2.95 | -20.67 | -224.18 | -183.24 | -488.73 | -1,303.55 | -3,476.83 | -9,273.43 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.